Circadian disruption reveals a correlation of an oxidative GSH/GSSG Redox shift with learning and impaired memory in an Alzheimer's disease mouse model

Journal of Alzheimer's Disease

Volumn 49, Issue 2, 2015, Pages 301-316

  Levault, Kelsey R ^a   Tischkau, Shelley A ^a   Brewer, Gregory J ^a,b  

^a SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Alzheimer's disease; APPSwDI NOS2 ; circadian disruption; glutathione; GSH; jet lag; learning; memory; redox; sleep

Indexed keywords

GLUTATHIONE; GLUTATHIONE DISULFIDE; AMYLOID PRECURSOR PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; NOS2 PROTEIN, MOUSE;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN LEVEL; CIRCADIAN RHYTHM; CONTROLLED STUDY; CORRELATION ANALYSIS; ENVIRONMENTAL STRESS; GENOTYPE; JET LAG; LEARNING; MEMORY DISORDER; MORRIS WATER MAZE TEST; MOUSE; MOUSE MODEL; NONHUMAN; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PRIORITY JOURNAL; AGE; ANALYSIS OF VARIANCE; ANIMAL; BRAIN; CHRONOBIOLOGY DISORDERS; COMPLICATION; DEFICIENCY; DISEASE MODEL; GENE EXPRESSION REGULATION; GENETICS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MEMORY DISORDERS; METABOLISM; MUTATION; PATHOLOGY; TRANSGENIC MOUSE;

AGE FACTORS; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN PRECURSOR; ANALYSIS OF VARIANCE; ANIMALS; BRAIN; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CHRONOBIOLOGY DISORDERS; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION; GLUTATHIONE; GLUTATHIONE DISULFIDE; HUMANS; MEMORY DISORDERS; MICE; MICE, TRANSGENIC; MUTATION; NADP; NITRIC OXIDE SYNTHASE TYPE II; OXIDATION-REDUCTION;

EID: 84948691445     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-150026     Document Type: Article

References (64)

1. Bettens K, Slegers K, Van Broeckhoven C (2010) Current status on Alzheimer disease molecular genetics: From past, to present, to future. Hum Mol Genet 19, R4-R11.
2. Hebert LE, Scherr PA, Bienias JL, Bennett DA, Evans DA (2003) Alzheimer disease in the US population: Prevalence estimates using the 2000 census. Arch Neurol 60, 1119-1122.
3. Frisardi V, Panza F, Seripa D, Imbimbo BP, Vendemiale G, Pilotto A, Solfrizzi V (2010) Nutraceutical properties of Mediterranean diet and cognitive decline: Possible underlying mechanisms. J Alzheimers Dis 22, 715-740.
4. Intlekofer KA, Cotman CW (2013) Exercise counteracts declining hippocampal function in aging and Alzheimer's disease. Neurobiol Dis 57, 47-55.
5. Fratiglioni L, Wang HX, Ericsson K, Maytan M, Winblad B (2000) Influence of social network on occurrence of dementia: A community-based longitudinal study. Lancet 355, 1315-1319.
6. Schmand B, Smit J, Lindeboom J, Smits C, Hooijer C, Jonker C, Deelman B (1997) Low education is a genuine risk factor for accelerated memory decline and dementia. J Clin Epidemiol 50, 1025-1033.
7. Naismith SL, Hickie IB, Terpening Z, Rajaratnam SW, Hodges JR, Bolitho S, Rogers NL, Lewis SJ (2014) Circadian misalignment and sleep disruption in mild cognitive impairment. J Alzheimers Dis 38, 857-866.
8. Bedrosian TA, Nelson RJ (2012) Pro: Alzheimer's disease and circadian dysfunction: Chicken or egg? Alzheimers Res Ther 4, 25.
9. Colton CA, Wilcock DM, Wink DA, Davis J, Van Nostrand WE, Vitek MP (2008) The effects of NOS2 gene deletion on mice expressing mutated human AbetaPP. J Alzheimers Dis 15, 571-587.
10. Jones DP (2002) Redox potential of GSH/GSSG couple: Assay and biological significance. Meth Enzymol 348, 93-112.
11. Jones DP, Carlson JL, Mody VC, Cai J, Lynn MJ, Sternberg P (2000) Redox state of glutathione in human plasma. Free Radical Biol Med 28, 625-635.
12. Ghosh D, Levault KR, Brewer GJ (2014) Relative importance of redox buffers GSH and NAD(P)H in age-related neurodegeneration and Alzheimer disease-like mouse neurons. Aging Cell 13, 631-640.
13. Brewer GJ (2010) Epigenetic oxidative redox shift (EORS) theory of aging unifies the free radical and insulin signaling theories. Exp Gerontol 45, 173-179.
14. Nakahata Y, Sahar S, Astarita G, Kaluzova M, Sassone-Corsi P (2009) Circadian control of the NAD+ salvage pathway by CLOCK-SIRT1. Science 324, 654-657.
15. Bellet MM, Sassone-Corsi P (2010) Mammalian circadian clock and metabolism-Dhe epigenetic link. J Cell Sci 123, 3837-3848.
16. RamseyKM, Yoshino J, Brace CS, Abrassart D, KobayashiY, Marcheva B, Hong HK, Chong JL, Buhr ED, Lee C, Takahashi JS, Imai S, Bass J (2009) Circadian clock feedback cycle through NAMPT-mediated NAD+ biosynthesis. Science 324, 651-654.
17. Imai S (2010) "Clocks in the NAD World: NAD as a metabolic oscillator for the regulation of metabolism and aging. Biochim Biophys Acta 1804, 1584-1590.
18. Wilcock DM, Lewis MR, Van Nostrand WE, Davis J, Previti ML, Gharkholonarehe N, Vitek MP, Colton CA (2008) Progression of amyloid pathology to Alzheimer's disease pathology in an amyloid precursor protein transgenic mouse model by removal of nitric oxide synthase 2. J Neurosci 28, 1537-1545.
19. Ghosh D, Levault KR, Barnett AJ, Brewer GJ (2012) A reversible early oxidized redox state that precedes macromolecular ROS damage in aging nontransgenic and 3xTg-AD mouse neurons. J Neurosci 32, 5821-5832.
20. Ghosh D, LeVault KR, Brewer GJ (2014) Dual-energy precursor and nuclear erythroid-related factor 2 activator treatment additively improve redox glutathione levels and neuron survival in aging and Alzheimer mouse neurons upstream of reactive oxygen species. Neurobiol Aging 35, 179-190.
21. Rost J, Rapoport S (1964) Reduction-potential of glutathione. Nature 201, 185.
22. D'Hooge R, De Deyn PP (2001) Applications of the Morris water maze in the study of learning and memory. Brain Res Brain Res Rev 36, 60-90.
23. Calabrese V, Sultana R, Scapagnini G, Guagliano E, Sapienza M, Bella R, Kanski J, Pennisi G, Mancuso C, Stella AM, Butterfield DA (2006) Nitrosative stress, cellular stress response, and thiol homeostasis in patients with Alzheimer's disease. Antioxid Redox Signal 8, 1975-1986.
24. Dean O, Bush AI, Berk M, Copolov DL, van den Buuse M (2009) Glutathione depletion in the brain disrupts short-Derm spatial memory in the Y-maze in rats and mice. Behav Brain Res 198, 258-262.
25. Moghekar A, O'Brien RJ (2012) Con: Alzheimer's disease and circadian dysfunction: Chicken or egg? Alzheimers Res Ther 4, 26.
26. Demarin V, Podobnik SS, Storga-Domic D, Kay G (2004) Treatment of Alzheimer's disease with stabilized oral nicotinamide adenine dinucleotide: A randomized, double-blind study. Drugs Exp Clin Res 30, 27-33.
27. Adair JC, Knoefel JE, Morgan N (2001) Controlled trial of Nacetylcysteine for patients with probable Alzheimer's disease. Neurology 57, 1515-1517.
28. Bedrosian TA, Nelson RJ (2013) Sundowning syndrome in aging and dementia: Research in mouse models. Exp Neurol 243, 67-73.
29. Coogan AN, Papachatzaki MM, Clemens C, Baird A, Donev RM, Joosten J, Zachariou V, Thome J (2011) Haloperidol alters circadian clock gene product expression in the mouse brain. World J Biol Psychiatry 12, 638-644.
30. Wulff K, Gatti S, Wettstein JG, Foster RG (2010) Sleep and circadian rhythm disruption in psychiatric and neurodegenerative disease. Nat Rev Neurosci 11, 589-599.
31. Creese J, Bedard M, Brazil K, Chambers L (2008) Sleep disturbances in spousal caregivers of individuals with Alzheimer's disease. Int Psychogeriatr 20, 149-161.
32. Cochrane A, Robertson IH, Coogan AN (2012) Association between circadian rhythms, sleep and cognitive impairment in healthy older adults: An actigraphic study. J Neural Transm 119, 1233-1239.
33. Tranah GJ, Blackwell T, Stone KL, Ancoli-Israel S, Paudel ML, Ensrud KE, Cauley JA, Redline S, Hillier TA, Cummings SR, YaffeK, Group SR (2011) Circadian activity rhythms and risk of incident dementia and mild cognitive impairment in older women. Ann Neurol 70, 722-732.
34. Dlugaj M, Weinreich G, Weimar C, Stang A, Dragano N, Wessendorf TE, Teschler H, Winkler A, Wege N, Moebus S, Mohlenkamp S, Erbel R, Jockel KH (2014) Sleep-disordered breathing, sleep quality, and mild cognitive impairment in the general population. J Alzheimers Dis 41, 469-473.
35. Zhou JN, Hofman MA, Swaab DF (1995) VIP neurons in the human SCN in relation to sex, age, and Alzheimer's disease. Neurobiol Aging 16, 571-576.
36. Stopa EG, Volicer L, Kuo-Leblanc V, Harper D, Lathi D, Tate B, Satlin A (1999) Pathologic evaluation of the human suprachiasmatic nucleus in severe dementia. J Neuropathol Exp Neurol 58, 29-39.
37. Coogan AN, Schutova B, Husung S, Furczyk K, Baune BT, Kropp P, Habler F, Thome J (2013) The circadian system in Alzheimer's disease: Disturbances, mechanisms, and opportunities. Biol Psychiatry 74, 333-339.
38. Cermakian N, Lamont EW, Boudreau P, Boivin DB (2011) Circadian clock gene expression in brain regions of Alzheimer's disease patients and control subjects. J Biol Rhythms 26, 160-170.
39. Liu RY, Zhou JN, Hoogendijk WJ, van Heerikhuize J, Kamphorst W, Unmehopa UA, Hofman MA, Swaab DF (2000) Decreased vasopressin gene expression in the biological clock of Alzheimer disease patients with and without depression. J Neuropathol Exp Neurol 59, 314-322.
40. Sterniczuk R, Dyck RH, Laferla FM, Antle MC (2010) Characterization of the 3xTg-AD mouse model of Alzheimer's disease: Part 1. Circadian changes. Brain Res 1348, 139-148.
41. Peterson GM, Moore RY (1980) Selective effects of kainic acid on diencephalic neurons. Brain Res 202, 165-182.
42. Colwell CS, Levine MS (1996) Glutamate receptor-induced toxicity in neostriatal cells. Brain Res 724, 205-212.
43. Bottum K, Poon E, Haley B, Karmarkar S, Tischkau SA (2010) Suprachiasmatic nucleus neurons display endogenous resistance to excitotoxicity. Exp Biol Med (Maywood) 235, 237-246.
44. Karmarkar SW, Bottum KM, Krager SL, Tischkau SA (2011) ERK/MAPK is essential for endogenous neuroprotection in SCN2.2 cells. PLoS One 6, e23493.
45. Xie L, Kang H, Xu Q, Chen MJ, Liao Y, Thiyagarajan M, O'Donnell J, Christensen DJ, Nicholson C, Iliff JJ, Takano T, Deane R, Nedergaard M (2013) Sleep drives metabolite clearance from the adult brain. Science 342, 373-377.
46. Castanon-Cervantes O, Wu M, Ehlen JC, Paul K, Gamble KL, Johnson RL, et al. (2010) Dysregulation of inflammatory responses by chronic circadian disruption. J Immunol 185, 5796-5805.
47. Loh DH, Navarro J, Hagopian A, Wang LM, Deboer T, Colwell CS (2010) Rapid changes in the light/dark cycle disrupt memory of conditioned fear in mice. PLoS One 5, 1-12.
48. Karatsoreos IN, Bhagat S, Bloss EB, Morrison JH, McEwen BS (2011) Disruption of circadian clocks has ramifications for metabolism, brain, and behavior. Proc Nat Acad Sci U S A 108, 1657-1662.
49. LeGates TA, Altimus CM, Wang H, Lee HK, Yang S, Zhao H, Kirkwood A, Weber ET, Hattar S (2012) Aberrant light directly impairs mood and learning through melanopsinexpressing neurons. Nature 491, 594-598.
50. Walker MP, LaFerla FM, Oddo SS, Brewer GJ (2013) Reversible epigenetic histone modifications and Bdnf expression in neurons with aging and from a mouse model of Alzheimer's disease. Age (Dordr) 35, 519-531.
51. Kann O, Schuchmann S, Buchheim K, Heinemann U (2003) Coupling of neuronal activity and mitochondrial metabolism as revealed by NAD(P)H fluorescence signals in organotypic hippocampal slice cultures of the rat. Neuroscience 119, 87-100.
52. Steullet P, Cabungcal JH, Kulak A, Kraftsik R, Chen Y, Dalton TP, Cuenod M, Do KQ (2010) Redox dysregulation affects the ventral but not dorsal hippocampus: Impairment of parvalbumin neurons, gamma oscillations, and related behaviors. J Neurosci 30, 2547-2558.
53. Steullet P, Neijt HC, Cuenod M, DoKQ(2006) Synaptic plasticity impairment and hypofunction of induced by glutathione deficit: Relevance to schizophrenia. Neuroscience 137, 807-819.
54. das Neves Duarte JM, Kulak A, Gholam-Razaee MM, Cuenod M, Gruetter R, Do KQ (2012) N-Acetylcysteine normalizes neurochemical changes in the glutathione-deficient schizophrenia mouse model during development. Biol Psychiatry 71, 1006-1014.
55. Bodhinathan K, Kumar A, Foster TC (2010) Intracellular redox state alters NMDA receptor response during aging through Ca2+/calmodulin-dependent protein kinase II. J Neurosci 30, 1914-1924.
56. Yang YJ, Wu PF, Long LH, Yu DF, WuWN, Hu ZL, Fu H, Xie N, Jin Y, Ni L, Wang JZ, Wang F, Chen JG (2010) Reversal of aging-Associated hippocampal synaptic plasticity deficits by reductants via regulation of thiol redox and NMDA receptor function. Aging Cell 9, 709-721.
57. Robillard JM, Gordon GR, Choi HB, Christie BR, MacVicar BA (2011) Glutathione restores the mechanism of synaptic plasticity in aged mice to that of the adult. PloS One 6, e20676.
58. Kumar A, Foster TC (2013) Linking redox regulation of NMDAR synaptic function to cognitive decline during aging. J Neurosci 33, 15710-15715.
59. Zelinski EL, Tyndall AV, Hong NS, McDonald RJ (2013) Persistent impairments in hippocampal, dorsal striatal, and prefrontal cortical function following repeated photoperiod shifts in rats. Exp Brain Res 224, 125-139.
60. Robillard JM, Gordon GR, Choi HB, Christie BR, MacVicar BA (2011) Glutathione restores the mechanism of synaptic plasticity in aged mice to that of the adult. PLoS One 6, e20676.
61. Zhao RR, Xu F, Xu XC, Tan GJ, Liu LM, Wu N, Zhang WZ, Liu JX (2015) Effects of alpha-lipoic acid on spatial learning and memory, oxidative stress, and central cholinergic system in a rat model of vascular dementia. Neurosci Lett 587, 113-119.
62. Rothman SM, Herdener N, Frankola KA, Mughal MR, Mattson MP (2013) Chronic mild sleep restriction accentuates contextual memory impairments, and accumulations of cortical Abeta and pTau in a mouse model of Alzheimer's disease. Brain Res 1529, 200-208.
63. Musiek ES, Lim MM, Yang G, Bauer AQ, Qi L, Lee Y, Roh JH, Ortiz-Gonzalez X, Dearborn JT, Culver JP, Herzog ED, Hogenesch JB, Wozniak DF, Dikranian K, Giasson BI, Weaver DR, Holtzman DM, Fitzgerald GA (2013) Circadian clock proteins regulate neuronal redox homeostasis and neurodegeneration. J Clin Invest 123, 5389-5400.
64. Rutter J, Reick M, Wu LC, McKnight SL (2001) Regulation of clock and NPAS2 DNA binding by the redox state of NAD cofactors. Science 293, 510-514.